Rémi Soula
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 30.04.2024
Karriereverlauf von Rémi Soula
Ehemalige bekannte Positionen von Rémi Soula
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADOCIA | Gründer | 16.12.2005 | 01.10.2019 |
Corporate Officer/Principal | 16.12.2005 | 01.10.2019 | |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Direktor/Vorstandsmitglied | - | - |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Corporate Officer/Principal | - | - |
CELLNOVO | Direktor/Vorstandsmitglied | 26.09.2016 | - |
Independent Dir/Board Member | 26.09.2016 | - |
Ausbildung von Rémi Soula
École Supérieure de Chimie Physique Électronique | Doctorate Degree |
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistik
International
Frankreich | 6 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Founder | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADOCIA | Health Technology |
Private Unternehmen | 3 |
---|---|
Cellnovo Group SA
Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
- Börse
- Insiders
- Rémi Soula
- Erfahrung